SCHEMBL27672087

SCHEMBL27672087

O=C(NC(F)(CCCc1ccccc1)C(=O)O)N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FKBP1A P62942 1/20 0.50
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CTSS P25774 3/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ POLB P06746 2/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ MLYCD O95822 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ FAAH O00519 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27651812 0.89 FKBP1A (0.46) FKBP1ACYP2C9CYP2C19MEN1KMT2A
SCHEMBL27672028 0.78 PKM (0.43) MEN1KMT2ASMN1; SMN2CTSS
SCHEMBL27672077 0.77 HTT (0.49) CYP2C9CYP2C19MEN1KMT2ASMN1; SMN2
SCHEMBL17117357 0.76 NAMPT (0.66) FKBP1ACYP2C9CYP2C19MEN1KMT2A
SCHEMBL17117403 0.75 NAMPT (0.67) FKBP1AMEN1KMT2ASMN1; SMN2
SCHEMBL9833782 0.73 FKBP1A (0.58) FKBP1ACYP2C9CYP2C19MEN1KMT2A
SCHEMBL28218804 0.72 MEN1 (0.74) FKBP1ACYP2C9CYP2C19MEN1KMT2A
SCHEMBL7068444 0.71 FKBP1A (0.82) FKBP1ACYP2C19SMN1; SMN2ALDH1A1TSHR
SCHEMBL1953978 0.70 FKBP1A (0.80) FKBP1ASMN1; SMN2POLBSIGMAR1MAPT
SCHEMBL8393626 0.69 USP2 (0.64) FKBP1ACYP2C9CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100543017-C Keto-oxadiazole derivatives as cathepsin inhibitors AVENTIS PHARMA INC (US) 2009-09-23 — — CN disclosed
CN-1898219-A Novel keto-oxadiazole derivatives as cathepsin inhibitors AVENTIS PHARMA INC (US) 2007-01-17 — — CN disclosed
Send feedback